Ozempic Is Finally Turning the Tide Against Obesity, New Data Shows (opens in new tab)

Covers GLP-1 use has more than quadrupled since 2021 as obesity rates continue to show signs of decline • Epic Research

As the rate of GLP-1 prescriptions in the U.S. has risen, the obesity rate has dropped.

Read the original article

Sign in to keep reading the full article.